Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin aspart vs. regular human insulin in gestational diabetes
NCT00065130Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2000
- Primary completion
- Dec 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin aspart in gestational diabetes mellitus (GDM), sponsored by Novo Nordisk. Started Apr 2000; status: completed.
02
Drugs
insulin aspart
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT00065130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00065130.